XBiotech
XBIT
XBIT
44 hedge funds and large institutions have $13M invested in XBiotech in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
23% less capital invested
Capital invested by funds: $17M → $13M (-$3.94M)
81% less call options, than puts
Call options by funds: $132K | Put options by funds: $708K
Holders
44
Holding in Top 10
–
Calls
$132K
Puts
$708K
Top Buyers
| 1 | +$155K | |
| 2 | +$124K | |
| 3 | +$104K | |
| 4 |
Millennium Management
New York
|
+$86K |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$59K |
Top Sellers
| 1 | -$2.19M | |
| 2 | -$138K | |
| 3 | -$105K | |
| 4 |
ProShare Advisors
Bethesda,
Maryland
|
-$93K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$85K |